Thompson Davis & Co’s Frontline FRO Stock Holding History

Thompson Davis & Co’s Portfolio FRO Stock Details FRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-25,525	Closed	-$310K	–	111
2022 Q4	$310K	Buy	+25,525	New	+$328K	0.44%	45

Other funds holding FRO

MAM

Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Thompson Davis & Co's FRO Position: Q1 2023 in Review

Thompson Davis & Co sold out of Frontline (FRO) in Q1 2023, closing a stake of 25,525 shares — an estimated $310K sold.

Thompson Davis & Co first reported a position in FRO in Q4 2022 and held it in 1 quarter. The position peaked at $310K in Q4 2022. 163 funds tracked by Wall St. Rank hold FRO as of Q1 2023.

Thompson Davis & Co reported no remaining Frontline position as of Q1 2023 after selling out during the quarter.
Thompson Davis & Co sold 25,525 Frontline shares in Q1 2023, an estimated $310K.
Thompson Davis & Co first reported a position in Frontline in Q4 2022 and held it in 1 quarter.
Thompson Davis & Co's Frontline position peaked at $310K in Q4 2022.
163 funds tracked by Wall St. Rank held Frontline as of Q1 2023.

Based on Thompson Davis & Co's 13F filing for Q1 2023, filed 10 May 2023.